AstraZeneca
Two CHMP recommendations for AstraZeneca: Imfinzi in first-line lung cancer, Calquence in chronic lymphocytic leukaemia
July 27, 2020Sales and Marketing AstraZeneca, CHMP, Calquence, EMA, Imfinzi
AstraZeneca has secured two new recommendations for approval of its products from the European Medicines Agency’s Committee for Medicinal Products …
AstraZeneca and Oxford University’s COVID-19 vaccine generates “robust immune responses” in early interim data
July 21, 2020Manufacturing and Production, Research and Development AstraZeneca, COVID-19, Oxford University, Vaccine, coronavirus
Interim Phase 1/2 findings have been released for the COVID-19 highly anticipated vaccine candidate in development from Oxford University and …
AstraZeneca secures accelerated FDA review for Farxiga for for CV death following heart attacks
July 17, 2020Medical Communications, Research and Development, Sales and Marketing AstraZeneca, FDA, farxiga, fast track
AstraZeneca has made it known that Farxiga (dapagliflozin) has secured Fast Track Designation from the FDA for the reduction of …
AstraZeneca’s Brilinta reduces the rate of stroke and death in patients with acute ischaemic stroke or transient ischaemic attack
July 16, 2020Business Services AZ, AstraZeneca, drug trials
AstraZeneca’s Phase 3 THALES trial showed that Brilinta (ticagrelor) significantly reduced the rate of death or stroke in patients with …
European green light for Lynparza in germline BRCA-mutated metastatic pancreatic cancer
July 8, 2020Research and Development, Sales and Marketing AstraZeneca, Cancer, Europe, MSD, lynparza
The European Commission has awarded approval to AstraZeneca and MSD’s Lynparza (olaparib) for germline BRCA-mutated (gBRCAm) metastatic pancreatic cancer, with …
AstraZeneca continues to ramp up COVID-19 vaccine production with new CMO partnership
June 25, 2020Manufacturing and Production AstraZeneca, COVID-19, Vaccine
AstraZeneca has continued to build its manufacturing capacity to deliver its COVID-19 vaccine candidate, developed in partnership with the University …
AstraZeneca’s BTK inhibitor Calquence shows promise in aiding recovery of severe COVID-19 patients
June 8, 2020Research and Development, Sales and Marketing AstraZeneca, COVID-19, Calquence, coronavirus, pharma
AstraZeneca has revealed more data in its efforts to find an effective therapy for those affected by the novel coronavirus.
AstraZeneca announces new partnerships to deliver two billion COVID-19 vaccine doses, with focus on developing countries
June 5, 2020Manufacturing and Production, Medical Communications AstraZeneca, COVID-19, Vaccine, coronavirus
As efforts to make an effective vaccine against COVID-19 available around the world continue to gather pace, AstraZeneca has revealed …
Lynparza secures CHMP recommendation in first-line BRCA-mutated metastatic pancreatic cancer
June 1, 2020Sales and Marketing AstraZeneca, Cancer, MSD, Pancreatic cancer, lynparza
Lynparza (olaparib), the PARP inhibitor developed by AstraZeneca and MSD, has just secured recommendation for approval from the European Medicines …
AstraZeneca pledges to manufacture 30m units of Oxford University’s COVID-19 vaccine
May 19, 2020Manufacturing and Production AstraZeneca, COVID-19, UK, Vaccine, coronavirus, pharma
AstraZeneca has provided an update on the partnership it forged with the University of Oxford in late April to push …
Lynparza combo authorised in US for first-line maintenance of HRD-positive advanced ovarian cancer
May 11, 2020Sales and Marketing AstraZeneca, Cancer, MSD, lynparza, ovarian cancer
Lynparza (olaparib), developed by AstraZeneca and MSD, has secured FDA approval when paired with bevacizumab as a first-line maintenance treatment …
AZ’s Farxiga becomes first FDA-approved SGLT2 inhibitor for heart failure with reduced ejection fraction
May 6, 2020Research and Development, Sales and Marketing AstraZeneca, FDA, farxiga, heart failure
The FDA has moved to approve an oral tablet formulation of AstraZeneca’s Farxiga (dapagliflozin) to reduce the risk of cardiovascular …
AstraZeneca joins forces with University of Oxford to develop and manufacture potential coronavirus vaccine
April 30, 2020Manufacturing and Production, Research and Development AstraZeneca, COVID-19, University of Oxford, coronavirus, pharma
A “landmark” partnership has been struck between AstraZeneca and the University of Oxford in the ongoing battle against COVID-19, with …
AstraZeneca to pit blood cancer drug Calquence against COVID-19 with the company’s fastest-ever trial launch
April 14, 2020Manufacturing and Production, Research and Development AstraZeneca, COVID-19, Calquence, coronavirus, pharma
As the R&D race against COVID-19 continues, AstraZeneca is poised to launch a global, multicentre clinical trial to test its …
Circassia terminates AstraZeneca partnership in exchange for £150m debt settlement
April 9, 2020Sales and Marketing AstraZeneca, Circassia, partnership, pharma, respiratory
Circassia Pharmaceuticals has announced its decision to break away from a partnership it forged with AstraZeneca UK back in 2017 …
